CDX-0158

N/A

Report date: 2024/06/04 20:00:06

Base Information

Drug NameCDX-0158
Drug Alias NameCDX-0158KTN-0158
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYale UniversityUniversity Of Toronto - St. George Campus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelldex Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A